NPOs have substantial potency for the μ-opioid receptor and an understudied propensity for adverse wellbeing results. Nitazenes are structurally unrelated to fentanyl, but are already observed to generally be as much as 1000-fold far more strong than morphine.1 The whole set of supply info with the European Drug Report 2024 which include metada